Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$7.88M$7.88Mderived+1.5% vs Q4 2022 Net Income-$11.19M-$11.19MderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$16,176,145N/M Operating Cash Flowderived$3,344,314+37.6% Free Cash Flowderived$1,629,401−33.6% Margins · derivedOperating margin-205.4%−210.6 pt vs Q4 2022
Net margin-142.1%−152.9 pt vs Q4 2022
ended Nov 30, 2023 · filed Feb 28, 2024 · 90 d after period end